Trials / Withdrawn
WithdrawnNCT04415541
Psychodynamic Psychotherapy for Psychosis
Psychodynamic Psychotherapy for Psychosis: An Empirical Pilot Study of Efficacy, Therapeutic Action, and Machine Learning Analysis of Within-Session Speech and Behavior
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 16 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The broad goals of our pilot study are to (1) determine whether psychodynamic psychotherapy for psychosis (PPfP), relative to treatment as usual (TaU), can maintain or augment clinical and functional benefits for patients who have achieved initial recovery in our coordinated specialty care (CSC) early psychosis treatment program; (2) to conduct novel empirical study of how various psychodynamic factors may inform candidate selection, mediate therapeutic effects, and influence relational aspects of the therapy; and (3) to conduct a detailed study of how features of therapist and patient speech and behavior influence therapeutic outcomes, therapeutic alliance alliance, and relational process. This registration focuses on the first goal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Psychodynamic Psychotherapy | Intensive psychotherapy that is psychodynamically oriented. |
| BEHAVIORAL | Usual Care | Conventional treatment offered in the community. |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2021-08-01
- Completion
- 2021-08-01
- First posted
- 2020-06-04
- Last updated
- 2021-10-25
Source: ClinicalTrials.gov record NCT04415541. Inclusion in this directory is not an endorsement.